Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Jiaqi Shi

Jiaqi Shi

University of Michigan, USA

Title: Intraductal papillary mucinous neoplasm (IPMN) versus intraductal tubulopapillary neoplasm (ITPN): How to differentiate these two entities?

Biography

Biography: Jiaqi Shi

Abstract

The differential diagnosis between an intraductal papillary mucinous neoplasm (IPMN) and intraductal tubulopapillary neoplasm (ITPN) can be difficult sometimes. IPMN is a mucinous cystic ductal neoplasm of the pancreas, whereas ITPN is mostly a solid intraductal neoplasm of the pancreas with no or minimum mucin. Therefore, gross examination and imaging is helpful to distinguish between these two entities. However, there is histologic overlap that could lead to erroneous diagnosis. Some of the histologic features in IPMN can resemble ITPN. Immunohistochemical stains of MUC5AC and MUC6 can also be helpful. Most of the IPMNs are positive for MUC5AC and negative for MUC6, with the exception of oncocytic type IPMN, while the opposite is true for ITPN. There are 4 subtypes of IPMN based on the epithelial cell lineage: Gastric, intestinal, pancreatobiliary and oncocytic types. Differentiating IPMN subtypes has clinical significance as they are associated with diverse prognosis. In the end, the most important question to address when evaluating IPMN or ITPN resection specimens is whether there is an invasive carcinoma component, because the prognosis is largely dependent on the answer of this question. A thorough examination of the lesion is desired to rule out an invasion.